Armata Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
AMEX
Armata Pharmaceuticals, Inc. has issued its proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for June 11, 2026, detailing proposals for director elections, executive compensation, and auditor ratification.
AMEX
Armata Pharmaceuticals will hold its 2025 Annual Meeting of Shareholders on June 12, 2025, to elect directors, approve executive compensation, and ratify the selection of its independent auditor.
AMEX
Armata Pharmaceuticals announces its 2024 Annual Meeting of Shareholders to be held on June 12, 2024, to elect directors, approve executive compensation, and ratify the selection of Ernst & Young LLP as the company's auditor.